Duarte (1)

Active, not recruiting (1)

phase 1 (1)

City of Hope Medical Center (1)

Mustang Bio, Inc. (1)

National Cancer Institute (NCI) (1)

allogeneic cd123car-cd28-cd3zeta-egfrt-expressing t-lymphocytes (1)

autologous cd123car-cd28-cd3zeta-egfrt-expressing t lymphocytes (1)

cyclophosphamide (1)

fludarabine phosphate (1)

laboratory biomarker analysis (1)

biological (1)

drug (1)

other (1)

Other (1)

Interventional (1)

early relapse of acute myeloid leukemia

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Active, not recruiting

Feb 17, 2022